SAB BIOTHERAPEUTICS, INC. (SABSW) Operating margin 2020–2024
SAB BIOTHERAPEUTICS, INC. (SABSW) operating margin by fiscal year — reported operating income divided by reported revenue.
-3244.9%FY2024 · since FY2020: 37.2% → -3244.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -3244.9% | -1544.3 pp |
| FY2023 | -1700.6% | -1579.6 pp |
| FY2022 | -121.0% | -99.0 pp |
| FY2021 | -22.0% | -59.2 pp |
| FY2020 | 37.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating cash flowSABSW Free cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW Shareholders’ equitySABSW overview →